Primary study · included by 1 review

Lang 2022

ProbableThe reviews cited this study without a PMID, DOI or NCT, so it is matched by first author and year. Two different studies by the same author in the same year could be merged here.

Included by

Identifying risk factors for osteoradionecrosis of the jaws: a systematic review and meta-analysis.

Non-Cochrane · aetiology · 2026 · cited as Lang 2022 · Fig. 2-5 forest plot; Table 1

Outcome this study informs	Pooled effect	Evidence	Certainty
Osteoradionecrosis of the jaws (ORNJ) T1-T2 tumor stage (frequency among patients who developed ORNJ) vs Same factor among irradiated patients who did not develop ORNJ · Not specified	OR 0.89 [0.47, 1.7]	2 studies · 481 participants	GRADE not reported
Osteoradionecrosis of the jaws (ORNJ) Tobacco use (frequency among patients who developed ORNJ) vs Same factor among irradiated patients who did not develop ORNJ · Not specified	OR 2.18 [0.73, 6.49]	7 studies · 3422 participants	GRADE not reported
Osteoradionecrosis of the jaws (ORNJ) Tobacco use (frequency among patients who developed ORNJ) vs Same factor among irradiated patients who did not develop ORNJ · Not specified	OR 2.56 [1.96, 3.34]	7 studies · 3422 participants	Moderate
Osteoradionecrosis of the jaws (ORNJ) Tobacco use (frequency among patients who developed ORNJ) vs Same factor among irradiated patients who did not develop ORNJ · Not specified	OR 3.44 [1.22, 9.73]	7 studies · 3930 participants	GRADE not reported
Osteoradionecrosis of the jaws (ORNJ) Chemotherapy (frequency among patients who developed ORNJ) vs Same factor among irradiated patients who did not develop ORNJ · Not specified	OR 1.42 [0.47, 4.29]	7 studies · 24677 participants	GRADE not reported
Osteoradionecrosis of the jaws (ORNJ) Chemotherapy (frequency among patients who developed ORNJ) vs Same factor among irradiated patients who did not develop ORNJ · Not specified	OR 0.72 [0.19, 2.72]	7 studies · 26135 participants	GRADE not reported
Development of osteoradionecrosis of the jaws (ORNJ) T1-T2 tumor stage vs T3-T4 tumor stage	OR 0.89 [0.46, 1.7]	2 studies · 481 participants	Moderate
Osteoradionecrosis of the jaws (ORNJ) Chemotherapy (frequency among patients who developed ORNJ) vs Same factor among irradiated patients who did not develop ORNJ · Not specified	OR 0.84 [0.74, 0.94]	7 studies · 24677 participants	Low

1 including review in total.